Feb 9, 2020: Indian Pharma firms are closely monitoring the outbreak of the coronavirus in China as it could impact the supply of active pharmaceutical ingredients in the country, if the situation in the neighbouring nation does not improve soon.
China accounted for 67.56 per cent of the total imports of bulk drugs and drug intermediates in the 2018-19 at USD 2,405.42 million. India imports bulk drugs / active pharmaceutical ingredients (APIs) from China for the manufacture of medicines including certain basic medicines.
The government has said earlier that most of the bulk product imports and APIs are being undertaken because of economic considerations.Â
On the government sector, India has revoked all visas issued to foreign nationals coming from China as it has stepped up efforts to fight coronavirus spread after 150 passengers were diagnosed with symptoms of the deadly virus and sent to isolation units.Â
It has also increased passenger screening at 21 airports, as well as at 12 major seaports and all minor ports.
https://www.coronaviral.org/india/prolongation-of-coronavirus-outbreak-in-china-could-hit-indian-pharma-sector-00208080
